Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
5.8
Year-on-year increase in operating income (¥100 million)Wording
Conditional
How definitive the wording is.Contents of this document
Presentation materials for financial resultsFirst quarter of the fiscal year ending March 20279 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales342.5 Hundreds of millions of yen+4.9%
Operating profit37.3 Hundreds of millions of yen+18.3%
Ordinary income55.8 Hundreds of millions of yen+23.2%
Net income32.8 Hundreds of millions of yen+2.0%
Results for the three months of the current quarter
Net Sales
342.5 Hundreds of millions of yen
Operating profit
37.3 Hundreds of millions of yen
Ordinary income
55.8 Hundreds of millions of yen
Net income
32.8 Hundreds of millions of yen
Full-year earnings forecast
Net Sales
1,522 Hundreds of millions of yen
Operating profit
142 Hundreds of millions of yen
Ordinary income
190 Hundreds of millions of yen
Net income
158 Hundreds of millions of yen
Earnings per share
¥294.8 per share
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Bridge charts showing the factors behind changes in consolidated and segment operating income, including price, volume, raw material prices, foreign exchange and other factors, with amounts shown
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rate
Yen/Dollar150
JPY/EUR175
New initiatives
- Testing in preparation for registration of the new insecticide NI-40
- Completion of a facility to increase production of the pharmaceutical excipient NISSO HPC
Segment results
Chemical Materials
Net Sales
94.2 Hundreds of millions of yen-5.5%
Operating profit
22.2 Hundreds of millions of yen+3.3%
Agribusiness
Net Sales
85.8 Hundreds of millions of yen+21.8%
Operating profit
4 Hundreds of millions of yen
Trading & Logistics
Net Sales
122 Hundreds of millions of yen+9.5%
Operating profit
8 Hundreds of millions of yen+18.6%
Engineering
Net Sales
17.9 Hundreds of millions of yen-26.0%
Operating profit
7 Hundreds of millions of yen+31.2%
Eco Solutions
Net Sales
22.6 Hundreds of millions of yen+9.1%
Operating profit
1.1 Hundreds of millions of yen+287.4%
Financial targets
Debt-to-equity ratio
Track Record0.18–0.29x
Capital expenditures
¥220 billions forecast for the fiscal year ending March 2027
Annual Dividend
Annual dividend per share¥160
Payout ratio
54.3 %
Acquisition of treasury shares
Previous repurchase authorization
- Since March 2019
- February 2020–October 2020: ¥5 billion
- February 2021–June 2021: ¥2 billion
- November 2023–March 2024: ¥2 billion
- May 2025–January 2026: ¥5 billion
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | 342.5 Hundreds of millions of yen (YoY +4.9%) |
| Operating profit | 37.3 Hundreds of millions of yen (YoY +18.3%) |
| Ordinary income | 55.8 Hundreds of millions of yen (YoY +23.2%) |
| Net income | 32.8 Hundreds of millions of yen (YoY +2.0%) |
| Results for the three months of the current quarter | Net Sales 342.5 Hundreds of millions of yen / Operating profit 37.3 Hundreds of millions of yen / Ordinary income 55.8 Hundreds of millions of yen / Net income 32.8 Hundreds of millions of yen |
| Full-year earnings forecast | Net Sales 1,522 Hundreds of millions of yen / Operating profit 142 Hundreds of millions of yen / Ordinary income 190 Hundreds of millions of yen / Net income 158 Hundreds of millions of yen / Earnings per share ¥294.8 per share |
| Segment results | Chemical Materials Net Sales 94.2 Hundreds of millions of yen (YoY -5.5%) / Operating profit 22.2 Hundreds of millions of yen (YoY +3.3%) / Agribusiness Net Sales 85.8 Hundreds of millions of yen (YoY +21.8%) / Operating profit 4 Hundreds of millions of yen / Trading & Logistics Net Sales 122 Hundreds of millions of yen (YoY +9.5%) / Operating profit 8 Hundreds of millions of yen (YoY +18.6%) / Engineering Net Sales 17.9 Hundreds of millions of yen (YoY -26.0%) / Operating profit 7 Hundreds of millions of yen (YoY +31.2%) / Eco Solutions Net Sales 22.6 Hundreds of millions of yen (YoY +9.1%) / Operating profit 1.1 Hundreds of millions of yen (YoY +287.4%) |
| Breakdown of Factors Affecting the Change | Bridge charts showing the factors behind changes in consolidated and segment operating income, including price, volume, raw material prices, foreign exchange and other factors, with amounts shown |
| Assumptions Underlying the Business Outlook | Exchange rate Yen/Dollar 150 / JPY/EUR 175 |
| Financial targets | Debt-to-equity ratio Track Record 0.18–0.29x |
| Annual Dividend | Annual dividend per share ¥160 |
| Payout ratio | 54.3 % |
| Acquisition of treasury shares | Previous repurchase authorization Since March 2019, February 2020–October 2020: ¥5 billion, February 2021–June 2021: ¥2 billion, November 2023–March 2024: ¥2 billion, May 2025–January 2026: ¥5 billion |
| Capital expenditures | ¥220 billions (forecast for the fiscal year ending March 2027) |
| New initiatives | Testing in preparation for registration of the new insecticide NI-40, Completion of a facility to increase production of the pharmaceutical excipient NISSO HPC |
Items this document does not state (14)
Gross Profit MarginOperating profit marginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planKey KPIsUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales increased in Agribusiness and Trading & Logistics, while sales declined in Chemical Materials. As the yen remained weak, foreign exchange gains were recorded, and costs related to the closure of the Mizushima Plant were recorded as an extraordinary loss.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.